Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology.
暂无分享,去创建一个
D. Leroith | M. Karas | S. Yakar | A. Butler | I. Gewolb | D LeRoith | S Yakar | A A Butler | I H Gewolb | M Karas | Y Okubo | Y. Okubo | D. Leroith | M.V. Karas | M. Karas
[1] S. Sciacchitano,et al. Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. , 1997, Endocrinology.
[2] G. Lienhard,et al. The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.
[3] D. Leroith,et al. Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.
[4] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[5] D. Accili,et al. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.
[6] T. Yagi,et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.
[7] B. Neel,et al. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. , 1994, The Journal of biological chemistry.
[8] S. D’Mello,et al. Insulin-Like Growth Factor and Potassium Depolarization Maintain Neuronal Survival by Distinct Pathways: Possible Involvement of PI 3-Kinase in IGF-1 Signaling , 1997, The Journal of Neuroscience.
[9] M. Shibuya,et al. Two species of human CRK cDNA encode proteins with distinct biological activities , 1992, Molecular and cellular biology.
[10] D. Leroith,et al. Insulin-Like Growth Factor-1 Inhibition of Apoptosis Is Associated with Increased Expression of the bcl-xL Gene Product. , 1997, Endocrinology.
[11] G. Lienhard,et al. A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.
[12] C. Kahn,et al. 4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*) , 1995, The Journal of Biological Chemistry.
[13] R. Dantzer,et al. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. , 1997, Journal of immunology.
[14] K. Siddle,et al. c phosphorylation and activation of the IGF-I receptor in src-transformed cells. , 1994, The Journal of biological chemistry.
[15] R. Dantzer,et al. Activation of phosphatidylinositol 3'-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. , 1997, Journal of immunology.
[16] Tony Pawson,et al. The Grb2-mSos1 Complex Binds Phosphopeptides with Higher Affinity than Grb2* , 1996, The Journal of Biological Chemistry.
[17] B. Margolis,et al. The cloning of Grb10 reveals a new family of SH2 domain proteins. , 1995, Oncogene.
[18] C. Ponting,et al. Pleckstrin's repeat performance: a novel domain in G-protein signaling? , 1996, Trends in biochemical sciences.
[19] Ling-mei Wang,et al. Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.
[20] C. Kahn,et al. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells , 1997, Molecular and cellular biology.
[21] E. Van Obberghen,et al. Evidence for a Differential Interaction of SHC and the Insulin Receptor Substrate-1 (IRS-1) with the Insulin-like Growth Factor-I (IGF-I) Receptor in the Yeast Two-hybrid System (*) , 1995, The Journal of Biological Chemistry.
[22] N. Heisterkamp,et al. Isolation and chromosomal localization of CRKL, a human crk-like gene. , 1993, Oncogene.
[23] M. Yaffe,et al. Insulin Receptor Substrate Proteins Create a Link between the Tyrosine Phosphorylation Cascade and the Ca2+-ATPases in Muscle and Heart* , 1997, The Journal of Biological Chemistry.
[24] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[25] S. Arkins,et al. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. , 1996, Journal of immunology.
[26] B. Margolis,et al. Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation. , 1992, The EMBO journal.
[27] J Downward,et al. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. , 1997, Trends in biochemical sciences.
[28] P G Pelicci,et al. Not all Shc's roads lead to Ras. , 1996, Trends in biochemical sciences.
[29] A. Craparo,et al. 14-3-3 (ε) Interacts with the Insulin-like Growth Factor I Receptor and Insulin Receptor Substrate I in a Phosphoserine-dependent Manner* , 1997, The Journal of Biological Chemistry.
[30] B. R. Dey,et al. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. , 1996, Molecular endocrinology.
[31] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[32] J. Olefsky,et al. Localization of the Insulin-like Growth Factor I Receptor Binding Sites for the SH2 Domain Proteins p85, Syp, and GTPase Activating Protein (*) , 1995, The Journal of Biological Chemistry.
[33] C. Ponting,et al. Pleckstrin's repeat performance , 1996 .
[34] E. Froesch,et al. Insulin-like growth factor I: physiology, metabolic effects and clinical uses. , 1996, Diabetes/metabolism reviews.
[35] J. Olefsky,et al. Interaction of a GRB-IR Splice Variant (a Human GRB10 Homolog) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.
[36] D. Clemmons,et al. Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.
[37] T. O’Neill,et al. Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (*) , 1995, The Journal of Biological Chemistry.
[38] S. Shoelson,et al. Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. , 1997, The Journal of biological chemistry.
[39] S. Shoelson,et al. Functional Roles of the Shc Phosphotyrosine Binding and Src Homology 2 Domains in Insulin and Epidermal Growth Factor Signaling* , 1996, The Journal of Biological Chemistry.
[40] C. Kahn,et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.
[41] J. Olefsky,et al. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. , 1994, The Journal of biological chemistry.
[42] D. Leroith,et al. Insulin-like Growth Factor-I Stimulates Tyrosine Phosphorylation of Endogenous c-Crk (*) , 1995, The Journal of Biological Chemistry.
[43] Role of IRS-1-GRB-2 complexes in insulin signaling. , 1994, Molecular and cellular biology.
[44] R. Baserga,et al. The Role of mGrb10α in Insulin-like Growth Factor I-mediated Growth* , 1997, The Journal of Biological Chemistry.
[45] Y. Yazaki,et al. Role of Insulin Receptor Substrate-1 and pp60 in the Regulation of Insulin-induced Glucose Transport and GLUT4 Translocation in Primary Adipocytes* , 1997, The Journal of Biological Chemistry.
[46] D. Baltimore,et al. SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. , 1994, Trends in biochemical sciences.
[47] C T Roberts,et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.
[48] M. White,et al. The Fyn Tyrosine Kinase Binds Irs-1 and Forms a Distinct Signaling Complex during Insulin Stimulation (*) , 1996, The Journal of Biological Chemistry.
[49] G. Superti-Furga,et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor–MAP kinase–fos signalling pathway , 1997, The EMBO journal.
[50] E. Van Obberghen,et al. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system. , 1996, Endocrinology.
[51] J. Ooi,et al. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. , 1997, The Journal of clinical investigation.
[52] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[53] M. White,et al. Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] N. Copeland,et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. , 1997, Molecular endocrinology.
[55] J. Groffen,et al. In Vivo Regulation of CrkII and CrkL Proto-oncogenes in the Uterus by Insulin-like Growth Factor-I , 1997, The Journal of Biological Chemistry.
[56] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[57] Adrian V. Lee,et al. Cloning, Chromosome Localization, Expression, and Characterization of an Src Homology 2 and Pleckstrin Homology Domain-containing Insulin Receptor Binding Protein hGrb10γ* , 1997, Journal of Biological Chemistry.
[58] C. Kahn,et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.